|  Help  |  About  |  Contact Us

Publication : Transcriptional repression of atherogenic inflammation: modulation by PPARdelta.

First Author  Lee CH Year  2003
Journal  Science Volume  302
Issue  5644 Pages  453-7
PubMed ID  12970571 Mgi Jnum  J:122915
Mgi Id  MGI:3715796 Doi  10.1126/science.1087344
Citation  Lee CH, et al. (2003) Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 302(5644):453-7
abstractText  The formation of an atherosclerotic lesion is mediated by lipid-laden macrophages (foam cells), which also establish chronic inflammation associated with lesion progression. The peroxisome proliferator-activated receptor (PPAR) gamma promotes lipid uptake and efflux in these atherogenic cells. In contrast, we found that the closely related receptor PPARdelta controls the inflammatory status of the macrophage. Deletion of PPARdelta from foam cells increased the availability of inflammatory suppressors, which in turn reduced atherosclerotic lesion area by more than 50%. We propose an unconventional ligand-dependent transcriptional pathway in which PPARdelta controls an inflammatory switch through its association and disassociation with transcriptional repressors. PPARdelta and its ligands may thus serve as therapeutic targets to attenuate inflammation and slow the progression of atherosclerosis.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

9 Bio Entities

Trail: Publication

0 Expression